STAT+: Flagship gets a Pentagon contract

The title of this STAT+ article indicates that Flagship Pioneering, a biotech venture firm, has received a contract from the Pentagon. However, the provided excerpt does not include any details about the contract's scope, value, or purpose.

The excerpt also highlights two other biotech developments: European drugmakers are urging governments to pay more for medicines, and venture capitalists are rushing to invest in osteoporosis drugs. This renewed interest follows new FDA guidance, as developing treatments for brittle bones has long been challenging due to safety concerns and regulatory barriers.